These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195 [TBL] [Abstract][Full Text] [Related]
4. Central nervous system manifestations of tuberculosis-associated immune reconstitution inflammatory syndrome during adalimumab therapy: a case report and review of the literature. Tanaka T; Sekine A; Tsunoda Y; Takoi H; Lin SY; Yatagai Y; Hayasihara K; Saito T Intern Med; 2015; 54(7):847-51. PubMed ID: 25832955 [TBL] [Abstract][Full Text] [Related]
5. Development of type 1 diabetes mellitus in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor alpha. Richez C; Blanco P; Gin H; Schaeverbeke T Clin Exp Rheumatol; 2006; 24(5):607. PubMed ID: 17181936 [No Abstract] [Full Text] [Related]
6. Palisaded neutrophilic and granulomatous dermatitis presenting in a patient with rheumatoid arthritis on adalimumab. Stephenson SR; Campbell SM; Drew GS; Magro CM J Cutan Pathol; 2011 Aug; 38(8):644-8. PubMed ID: 21592182 [TBL] [Abstract][Full Text] [Related]
7. Adalimumab (a fully human anti-tumour necrosis factor alpha monoclonal antibody) in the treatment of active rheumatoid arthritis: the initial results of five trials. Rau R Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii70-3. PubMed ID: 12379628 [No Abstract] [Full Text] [Related]
9. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750 [TBL] [Abstract][Full Text] [Related]
10. [Pulmonary tuberculosis with cerebellar lesion in a patient after anti-TNF-alpha (infliximab) treatment for rheumatoid arthritis]. Ubukata M; Takayanagi N; Yanagisawa T; Miyahara Y; Kubota M; Hara K; Saitoh H; Tokunaga D; Kurashima K; Sugita Y Nihon Kokyuki Gakkai Zasshi; 2005 Apr; 43(4):247-51. PubMed ID: 15966373 [TBL] [Abstract][Full Text] [Related]
11. Adalimumab-induced interstitial pneumonia with an improvement of pre-existing rheumatoid arthritis-associated lung involvement. Komiya K; Ishii H; Fujita N; Oka H; Iwata A; Sonoda H; Kadota J Intern Med; 2011; 50(7):749-51. PubMed ID: 21467710 [TBL] [Abstract][Full Text] [Related]
12. Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study. Weisman MH; Moreland LW; Furst DE; Weinblatt ME; Keystone EC; Paulus HE; Teoh LS; Velagapudi RB; Noertersheuser PA; Granneman GR; Fischkoff SA; Chartash EK Clin Ther; 2003 Jun; 25(6):1700-21. PubMed ID: 12860493 [TBL] [Abstract][Full Text] [Related]
13. Pulmonary nodulosis and aseptic granulomatous lung disease occurring in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha-blocking agent: a case series. Toussirot E; Berthelot JM; Pertuiset E; Bouvard B; Gaudin P; Wendling D; le Noach J; Lohse A; Lecuyer E; Cri L J Rheumatol; 2009 Nov; 36(11):2421-7. PubMed ID: 19797509 [TBL] [Abstract][Full Text] [Related]
14. Oral tuberculosis associated with a treatment with anti-rheumatic drugs. Kolokotronis A; Avramidou E; Zaraboukas T; Mandraveli K; Alexiou S; Antoniades D J Oral Pathol Med; 2006 Feb; 35(2):123-5. PubMed ID: 16430744 [TBL] [Abstract][Full Text] [Related]
15. Adalimumab-induced noncaseating granuloma in the bone marrow of a patient being treated for rheumatoid arthritis. Metyas SK; Tadros RM; Arkfeld DG Rheumatol Int; 2009 Feb; 29(4):437-9. PubMed ID: 18762943 [TBL] [Abstract][Full Text] [Related]
16. Adalimumab, etanercept, and infliximab utilization patterns and drug costs among rheumatoid arthritis patients. Carter CT; Changolkar AK; Scott McKenzie R J Med Econ; 2012; 15(2):332-9. PubMed ID: 22168788 [TBL] [Abstract][Full Text] [Related]
17. Sarcoid-like granulomatosis in patients treated with anti-TNFα factors. A case report and review of the literature. Kanellopoulou T; Filiotou A; Kranidioti H; Dourakis SP Clin Rheumatol; 2011 Apr; 30(4):581-3. PubMed ID: 20972592 [TBL] [Abstract][Full Text] [Related]
18. Adalimumab-induced central nervous system demyelination in a patient with rheumatoid arthritis. Shirah B; Altwirgi S; Faridoon I; Alghamdi S Neuroradiol J; 2024 Apr; 37(2):234-236. PubMed ID: 37125695 [TBL] [Abstract][Full Text] [Related]
19. November 2006: a 39-year-old man with new onset seizures. Robinson CA Brain Pathol; 2007 Apr; 17(2):253-4. PubMed ID: 17388957 [No Abstract] [Full Text] [Related]
20. Tuberculous peritonitis after treatment with adalimumab. Antolín J; Azahara M; Hernández C; Blanco M; Mao L; Cigüenza R Scand J Infect Dis; 2008; 40(8):677-8. PubMed ID: 18979608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]